A 59-year-old man presented with 20 years history of low back pain. The pain was mechanical in nature with early morning stiffness of less than 15 minutes. The patient was followed-up with a diagnosis of diffuse idiopathic skeletal hyperostosis (DISH) by the other physicians. He had partial response to analgesics.
On inquiry, the patient reported that since childhood his urine had turned a dark color on exposure to air. Physical examination revealed blue-black pigmentation of the sclera and ear pinna bilaterally (
Figure 1). On laboratory, full blood count, calcium, phosphorus, alkaline phosphatase, erythrocyte sedimentation rate, C-reactive protein and rheumatoid factor were normal. HLA B-27 was also negative. Measurement of 24 hours urinary homogentisic acid levels was 957
μmol/mmol creatinine (reference value, <1
μmol/mmol creatinine). X-ray showed multilevel intervertebral disc space narrowing associated with disc calcifications of the thoracolumbar spine (
Figure 1). The diagnosis of ochronosis was established, ascorbic acid and nitisinone were started for the patient. Protein restriction was made in his diet.
 | Figure 1Photographs show blue-black pigmentation of the sclera (arrow) (A) and ear pinna (arrowhead) (B), X-ray of the thoracolumbar spine, multilevel intervertebral disc space narrowing associated with disc calcifications (C∼E). We received the patient’s consent form about publishing all photographic materials. 
|
Ochronosis is a rare hereditary autosomal recessive disorder characterized by an excess of homogentisic acid deposits in the tissues. The incidence of ochronosis (alkaptonuria) is estimated at 1 case in 250,000 to 1 million live births [
1]. Ochronotic arthropathy generally appears in the third decade, commonly affects in which weight bearing joints and the thoracolumbar spine. Narrowing of the intervertebral spaces and widespread, thin, linear, wafer-like disc calcification are diagnostic findings seen on spine radiographs [
2]. A potential agent called 2 mg of daily nitisinone has been shown to decrease clinical progression of ochronosis [
3]. Disc calcifications must be distinguished from those of the following: ankylosing spondylitis, juvenile idiopathic arthritis, DISH, calcium pyrophosphate dehydrate crystal deposition disease, hyperparathyroidism, Klippel-Feil syndrome, and congenital and acquired fusions of the spine [
4]. The diagnosis of ochronosis must be considered for any patient with multilevel vertebral-body disc involvement.
Go to :
